NCT00389402View on ClinicalTrials.gov

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

July 31, 2008

Conditions

HIV Infections

Interventions

DRUG

saquinavir/ritonavir

DRUG

atazanavir/ritonavir

Trial Locations (1)

1105 AZ

Academic Medical Centre, University of Amsterdam, Amsterdam

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

International Antiviral Therapy Evaluation Center

OTHER